+91 8617752708

British Journal of Medicine and Medical Research, ISSN: 2231-0614,Vol.: 11, Issue.: 6

Review Article

Use of Recombinant Factor VIIa in Obstetrics

 

Neena Chuni1* and Sachchithanantham Kanagasabai1

1Department of Obstetrics and Gynaecology, Melaka Manipal Medical College, Malaysia.

Article Information
Editor(s):
(1) Yoshihiro Nishida , Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Yuhu-City, Japan.
Reviewers:
(1) Magdy Abdelrahman Mohamed, Sohag University, Egypt.
(2) D. S. Sheriff, Benghazi University, Benghazi, Libya.
Complete Peer review History: http://sciencedomain.org/review-history/11632

Abstracts

The objective of this review article was to evaluate the current literature on the increasing off-label use of rFVIIa in the management of critical obstetric haemorrhage. Given the lack of high-level evidence, there is a need to review the clinical indications, observed response and adverse events. This review is designed to aid practitioners in deciding when and how to administer rFVIIa; since the current evidence from observational studies shows that benefits outweigh risks in its use as an adjunct to conventional treatment in massive haemorrhage. However, pregnancy is a potentially thrombogenic state, hence a cautious approach is required in patients with risk factors for thromboembolic complications.

Keywords :

rFVII; obstetric haemorrhage; postpartum acquired haemophilia; Jehovah’s witnesses.

Full Article - PDF    Page 1-14

DOI : 10.9734/BJMMR/2016/20737

Review History    Comments

Our Contacts

Guest House Road, Street no - 1/6,
Hooghly, West Bengal,
India

+91 8617752708

 

Third Floor, 207 Regent Street
London, W1B 3HH,
UK

+44 20-3031-1429